BullFrog AI issues shareholder letter highlighting recent progress, outlook

4 hours ago 1

Skip to navigation Skip to main contented Skip to close file

TipRanks

Tue, April 14, 2026 astatine 8:29 AM CDT 1 min read

BullFrog AI (BFRG) issued a missive to shareholders from laminitis and CEO Vin Singh stating the institution has secured the fiscal runway to execute its strategy into precocious 2027 and is successful progressive discussions with pharmaceutical and biotechnology organizations. “BullFrog AI enters the 2nd 4th of 2026 well-capitalized, astatine commercialized stage, and successful progressive discussions with consequential pharmaceutical and biotechnology organizations,” said Vin Singh, laminitis and CEO. “We conscionable closed our archetypal statement with a apical 5 planetary pharmaceutical company, secured the fiscal runway to execute our strategy into precocious 2027, and are profoundly engaged with an manufacture that is nary longer evaluating whether to clasp AI-driven cause find – but deciding with whom”.

Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
Discover top-performing banal ideas and upgrade to a portfolio of marketplace leaders with Smart Investor Picks

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See today’s best-performing stocks connected TipRanks >>

Read More connected BFRG:

Disclaimer & DisclosureReport an Issue

3 Penny Stocks to Watch Now, 4/2/26
BullFrog AI Signs Major AI Drug Discovery Partnership
Bullfrog AI enters commercialized statement with pharmaceutical company
BullFrog AI Faces Nasdaq Noncompliance, Delisting Risk Looms

Read Entire Article